- Capital Cube•13 days ago
Click here to see latest analysis*Disclaimer : This is as of previous day’s closeETF’s with exposure to Infinity Pharmaceuticals, Inc.Here are 5 ETF’s with the largest exposure to INFI-US. Comparing the performance and risk of Infinity Pharmaceuticals, Inc. with the ETF’s that have exposure to it gives us some ETF choices that could give us […] (Read more...) The post ETF’s with exposure to Infinity Pharmaceuticals, Inc. : July 18, 2016 appeared first on CapitalCube.
- Zacks•last month
Infinity Pharmaceuticals (INFI) regained rights to develop and commercialize duvelisib; the company plans to eliminate 100 positions across the organization.
Infinity Pharmaceuticals, Inc.NasdaqGS
After hours: 1.68-0.00 (-0.02%) as of 4:46 PM EDT
|Bid||1.20 x 200|
|Ask||1.75 x 100|
|52wk Range||1.24 - 10.85|
|Day's Range||1.55 - 1.72|
|Avg Vol (3m)||1,469,558|
As of 4:00 PM EDT. Market closed.